Digital Heroes Marks 2,000 Brand Launches Across 55 Countries Through Global Technology Services 
ANT Law Firm Strengthens Its Orlando Legal Services for Car Accident, Slip and Fall, and Wrongful Death Victims 
LumenIsle Launches Australian Market Service Review and International Video Traceability Initiative for Memorial Diamonds 
HiBob Named Best HR Management Software in the UK for 2026 
Ionik Announces 30-Day Extension of Senior Debt Facility Medicenna Announces That Initiation of MDNA11 Phase 1/2 Study is on Track; Update to be Provided at the PropThink Digital Conference
– Phase 1/2 ABILITY Study is designed to evaluate MDNA11, a potentially best-in-class IL-2 Superkine,…
Allogene Therapeutics to Report Second Quarter Financial Results on August 4, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield” to Discuss Concussion Treatments
IRVINE, CA, July 27, 2021 (GLOBE NEWSWIRE) — Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company”…
Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent
Potential for Affordable COVID-19 Immunization Coverage in Underserved African Countries Arrangement includes C1 COVID-19 vaccine…
Cidara Therapeutics to Present New Data for Rezafungin at the International Society for Human and Animal Mycology (ISHAM) Asia Congress
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Rhythm Pharmaceuticals to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
BOSTON, July 27, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed…
Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tuesday, August 10, 2021
Management to host conference call and webcast at 8:30 AM ET on that day NEVE…
BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad Católica de Chile
VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Radius Health Business Update
Added 5,000+ new TYMLOS patients in Q2, 2021, up 40+% vs. Q2, 2020 and 3%…
Kronos Bio Announces FDA Clearance of Investigational New Drug Application for Lanraplenib (LANRA) for Treatment of Patients with Acute Myeloid Leukemia (AML)
Company intends to develop LANRA as a once-daily chronic treatment for genetically-defined AML patients Two…
VYNE Therapeutics to Report Second Quarter 2021 Financial Results on August 12, 2021
BRIDGEWATER, N.J., July 27, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
Entasis Therapeutics and Zai Lab Complete Patient Enrollment in the ATTACK Phase 3 Registrational Clinical Trial of Sulbactam-Durlobactam
– First clinical trial to specifically study confirmed carbapenem-resistant Acinetobacter…
Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021
MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (“TLIS”), a company…
AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
AFFiRiS to receive AC Immune stock valued at USD 58.7 million in exchange for its…
LAVA Therapeutics Announces Appointment of Amy Garabedian as General Counsel and Corporate Secretary
UTRECHT, The Netherlands and PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
SpringWorks Therapeutics Appoints Dr. James Cassidy as Chief Medical Officer
STAMFORD, Conn., July 27, 2021 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage…
Kinnate Biopharma Inc. to Participate in the 2021 Wedbush PacGrow Healthcare Conference
SAN FRANCISCO and SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
Capricor Therapeutics Announces the Appointment of Karimah Es Sabar to its Board of Directors
LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor” or “the Company”) (NASDAQ:…
BioVie Presents Data Supporting use of NE3107 in the Treatment of Alzheimer’s Disease at 2021 Alzheimer’s Association International Conference
NE3107 Is the First Potentially Disease Modifying, Anti-Inflammatory Insulin Sensitizer Therapy In A Pivotal Phase…
GBT to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
SOUTH SAN FRANCISCO, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…